Related Experiment Video
Updated: Jun 20, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
Innate immune signals in atherosclerosis
Anna M Lundberg1, Göran K Hansson
1Center for Molecular Medicine, L8:03, Department of Medicine, Karolinska Institute, Stockholm SE-17176, Sweden. Anna.Lundberg@ki.se
Innate immune mechanisms, particularly pattern-recognition receptors (PRRs) and Toll-like receptors (TLRs), drive atherosclerosis by promoting inflammation and lipid retention in arteries. Understanding these pathways is key to targeting this chronic disease.
Area of Science:
- Immunology
- Cardiovascular Biology
- Pathology
Background:
- Atherosclerosis involves lipid retention and inflammation in the arterial intima.
- Innate immune mechanisms, including pattern-recognition receptors (PRRs), are central to the development of atherosclerosis.
- PRRs recognize pathogen-associated molecular patterns and damage-associated molecular patterns, initiating inflammatory responses.
Purpose of the Study:
- To review the innate immune mechanisms within atherosclerotic plaques.
- To focus on Toll-like receptors (TLRs) and their role in atherogenesis.
- To explore the cross-talk between TLRs and other PRRs and their impact on lesion inflammation.
Main Methods:
- Literature review focusing on innate immunity in atherosclerosis.
- Analysis of PRR activation and signalling pathways in atherosclerotic lesions.
- Examination of the role of scavenger receptors and TLRs in foam cell formation and inflammation.
Main Results:
- Innate immune signals from various sources activate PRRs in atherosclerotic lesions.
- Scavenger receptors contribute to foam cell formation by mediating lipoprotein uptake.
- TLRs induce pro-inflammatory cytokines and antigen-specific immune responses, influencing lesion inflammation.
Conclusions:
- Innate immune mechanisms, especially PRRs and TLRs, are critical drivers of inflammation in atherosclerosis.
- TLR signalling cascades significantly impact the inflammatory processes within atherosclerotic plaques.
- Targeting innate immune pathways presents a potential therapeutic strategy for atherosclerosis.
Related Concept Videos
Inflammation
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
Atherosclerosis III: Management
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Coronary Artery Disease I: Introduction
